These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7839409)
1. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose alpha(1-3)galactose reactive lectin. Vaughan HA; McKenzie IF; Sandrin MS Transplantation; 1995 Jan; 59(1):102-9. PubMed ID: 7839409 [TBL] [Abstract][Full Text] [Related]
2. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Sandrin MS; McKenzie IF Immunol Rev; 1994 Oct; 141():169-90. PubMed ID: 7532618 [TBL] [Abstract][Full Text] [Related]
4. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11391-5. PubMed ID: 7504304 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells. Azimzadeh A; Wolf P; Thibaudeau K; Cinqualbre J; Soulillou JP; Anegon I Transplantation; 1997 Oct; 64(8):1166-74. PubMed ID: 9355835 [TBL] [Abstract][Full Text] [Related]
6. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Oriol R; Ye Y; Koren E; Cooper DK Transplantation; 1993 Dec; 56(6):1433-42. PubMed ID: 8279016 [TBL] [Abstract][Full Text] [Related]
7. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. McKenzie IF; Xing PX; Vaughan HA; Prenzoska J; Dabkowski PL; Sandrin MS Transpl Immunol; 1994 Jun; 2(2):81-6. PubMed ID: 7953322 [TBL] [Abstract][Full Text] [Related]
8. A murine model of antibody-mediated hyperacute rejection by galactose-alpha(1,3)galactose antibodies in Gal o/o mice. McKenzie IF; Li YQ; Patton K; Thall AD; Sandrin MS Transplantation; 1998 Sep; 66(6):754-63. PubMed ID: 9771839 [TBL] [Abstract][Full Text] [Related]
9. Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation. Sandrin MS; Osman N; McKenzie IF Front Biosci; 1997 Apr; 2():e1-11. PubMed ID: 9159186 [TBL] [Abstract][Full Text] [Related]
10. Oligosaccharides and discordant xenotransplantation. Cooper DK; Koren E; Oriol R Immunol Rev; 1994 Oct; 141():31-58. PubMed ID: 7868156 [TBL] [Abstract][Full Text] [Related]
12. Target antigens of hyperacute xenogeneic rejection in the rat to guinea pig to rat discordant combinations. Calmus Y; Ayani E; Cardoso J; Chéreau C; Kahan A; Houssin D; Weill B Transplantation; 1993 Oct; 56(4):778-85. PubMed ID: 8212195 [TBL] [Abstract][Full Text] [Related]
13. Human naturally occurring antibodies to pig xenografts. Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF Transplant Proc; 1994 Jun; 26(3):1392. PubMed ID: 7518133 [No Abstract] [Full Text] [Related]
14. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. LaVecchio JA; Dunne AD; Edge AS Transplantation; 1995 Oct; 60(8):841-7. PubMed ID: 7482745 [TBL] [Abstract][Full Text] [Related]
15. Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies. Saethre M; Sølvik UØ; Haraldsen G; Fiane AE; Boretti E; Thorsby E; Platt JL; Mollnes TE Xenotransplantation; 2002 Sep; 9(5):350-8. PubMed ID: 12199866 [TBL] [Abstract][Full Text] [Related]
16. The footprint of antibody bound to pig cells: evidence of complex surface topology. Everett ML; Lin SS; Worrell SS; Platt JL; Parker W Biochem Biophys Res Commun; 2003 Feb; 301(3):751-7. PubMed ID: 12565844 [TBL] [Abstract][Full Text] [Related]
17. Xenoantigens and xenoantibodies. Cooper DK Xenotransplantation; 1998 Feb; 5(1):6-17. PubMed ID: 9507728 [TBL] [Abstract][Full Text] [Related]
18. Monomorphic and polymorphic carbohydrate antigens on pig tissues: implications for organ xenotransplantation in the pig-to-human model. Oriol R; Barthod F; Bergemer AM; Ye Y; Koren E; Cooper DK Transpl Int; 1994; 7(6):405-13. PubMed ID: 7532414 [TBL] [Abstract][Full Text] [Related]
19. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury. van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415 [TBL] [Abstract][Full Text] [Related]